AGTC Partners
Latest statistics and disclosures from AGTC Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Acceleron Pharma, Bg Medicine, and represent 100.00% of AGTC Partners's stock portfolio.
- Reduced shares in these 1 stock: Bg Medicine.
- AGTC Partners was a net seller of stock by $-903k.
- AGTC Partners has $14M in assets under management (AUM), dropping by -26.57%.
- Central Index Key (CIK): 0001419730
Portfolio Holdings for AGTC Partners
AGTC Partners holds 2 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Acceleron Pharma | 97.4 | $13M | 531k | 24.90 |
|
|
| Bg Medicine | 2.6 | $354k | -71% | 863k | 0.41 |
|
Past Filings by AGTC Partners
SEC 13F filings are viewable for AGTC Partners going back to 2014
- AGTC Partners 2015 Q3 filed Nov. 13, 2015
- AGTC Partners 2015 Q2 filed July 28, 2015
- AGTC Partners 2015 Q1 filed April 30, 2015
- AGTC Partners 2014 Q4 filed Feb. 12, 2015